INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "COMBINATION OF ZONGERTINIB WITH A SOS1 INHIBITOR FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Oct. 13 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 INGELHEIM AM RHEIN) filed a patent application (PCT/EP2025/058892) for "COMBINATION OF ZONGERTINIB WITH A SOS1 INHIBITOR FOR USE IN THE TREATMENT OF CANCER" on Apr 02, 2025. With publication no. WO/2025/210042, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHENK, Robyn Leigh (Boehringer Ingelheim International GmbH, Global PatentsBinger Strasse 17355216 INGELHEIM AM RHEIN), BAUM, Anke (Boehringer Ingelheim International GmbH, Global Pat...